MiMedx Group Reveals Robust Q4 2025 Results Amidst Strategic Growth Initiatives
$MDXG Reports Strong Q4 2025 Performance, Exceeding Revenue Forecasts Key Takeaways MiMedx Group, Inc. (MDXG) reported Q4 2025 revenue of $110.3 million, marking a significant 15.2% increase year-over-year, surpassing analyst consensus, per Q4 2025 Earnings Call Transcript. Net income for the quarter reached $12.5 million, translating to $0.09 per diluted share, demonstrating improved profitability and […]
MiMedx Group Reveals Robust Q4 2025 Results Amidst Strategic Growth Initiatives Read More »